Bullboard - Stock Discussion Forum Alpha Cognition Inc C.ACOG

Alternate Symbol(s): ACOGF

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

Add To Watchlist

CSE:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG developing ALS and Dementia treatment

View:

Post by StockHawk1 on Nov 15, 2021 6:14pm

$ACOG developing ALS and Dementia treatment

I'm always happy to put my money in a company that is going to do good in the world as well as do good on the market. Alpha Cognition Inc. ( $ACOG.V ACOGF ) is in the clinical stages of developing treatments for Alzheimer's Disease, ALS, and other under-served neurodegenerative diseases.

The two main drugs they are developing are ALPHA-1062 and ALPHA-602:

Alpha-1062 is very similar to a drug that was developed by J&J and approved in the mid-2000s but $ACOG's version is optimized to minimize side effects.
Alpha-602 is a progranulin gene therapy drug that has been shown to help with a number of disease states and could possibly become a curative option for ALS.

From a financial POV $ACOG is looking solid, having gained $14.4M from their Canadian IPO (which they intend to use for commercialization of ALPHA-1062 and ALPHA-602)

$ACOG is slightly down today trading at $1.12 (down 2.6%) so it could be a good time to get in.

https://www.alphacognition.com/

137